One of the main challenges of contemporary medicine is posed by the resistance of pathogens to antibiotics. An important step ...

Tuberculosis has such a grip on the world that it has overtaken COVID-19 to once again become the deadliest infectious ...

The WHO's latest report on tuberculosis shows that it's once again the leading cause of death from a single infectious ...

Tuberculosis is once again the infectious disease responsible for the most deaths worldwide, according to a Tuesday ...

Tuberculosis is again the leading cause of deaths from infectious disease after COVID-19 displaced it briefly during the ...

Tuberculosis was the leading killer among infectious diseases in 2023, the World Health Organization said. While the number ...

Combination therapy with rifampicin and polymixin is one of the most discussed alternatives for the treatment of MDR Gram-negative bacterial infection. The usefulness of colistin has been clearly ...

In 2023, of the estimated 400,000 people who developed MDR or rifampicin-resistant TB, only 44% were accurately diagnosed and ...

According to the data, treatment success rates in India stood at 89% for drug-susceptible TB cases, 73% for cases with ...

The World Health Organization (WHO) today published a new report on tuberculosis revealing that approximately 8.2 million people were newly diagnosed with TB in 2023 – the highest number recorded ...

WHO in a new report on tuberculosis, said that approximately 8.2 million people were newly diagnosed with TB in 2023 ...

One of the main challenges of contemporary medicine is posed by the resistance of pathogens to antibiotics. An important step in countering it has now been made by researchers from IOCB Prague, in ...